Development of in vitro toxicity expression assays

Information

  • Research Project
  • 6841043
  • ApplicationId
    6841043
  • Core Project Number
    R43CA110876
  • Full Project Number
    1R43CA110876-01
  • Serial Number
    110876
  • FOA Number
    PA-02-75
  • Sub Project Id
  • Project Start Date
    9/1/2004 - 20 years ago
  • Project End Date
    2/28/2007 - 17 years ago
  • Program Officer Name
    MOXEY-MIMS, MARVA M.
  • Budget Start Date
    9/1/2004 - 20 years ago
  • Budget End Date
    2/28/2007 - 17 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/30/2004 - 20 years ago

Development of in vitro toxicity expression assays

[unreadable] DESCRIPTION (provided by applicant): [unreadable] The goal of this proposal is to develop and validate a process for generating in vitro, gene expression assays for toxicology. Specifically, we propose to derive gene signatures, that can classify chemicals according to specific liver pathology endpoints, using whole genome expression profiling in rat primary hepatocytes in vitro and to convert the gene signatures into efficient, high throughput, validated assays for use as a cost efficient, fast screening tool. The project will utilize the joint expertise of Iconix researchers in identifying toxicological gene signatures using compound treatment and global, microarray gene expression analysis, and Althea researchers for translating these signatures into high throughput gene expression assays using highly multiplexed, universal-primed rtPCR (UP-rtPCR). In this Phase I proposal, we intend to demonstrate the process for one general hepatoxicity endpoint, Cholestatis, and one general toxicity endpoint, DNA damage. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    97654
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:97654\
  • Funding Mechanism
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ICONIX PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
    018099247
  • Organization City
    MOUNTAIN VIEW
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94043
  • Organization District
    UNITED STATES